ArticlePloS one2026
Public participation in healthcare safety: A tripartite evolutionary game model with evidence from diverse international cases.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As healthcare systems grow in complexity, ensuring medical safety requires moving beyond traditional top-down regulation. While public participation is increasingly recognized as a vital component, a robust, generalizable framework to guide its implementation has been lacking. This study addresses this critical gap by proposing and rigorously validating a tripartite evolutionary game model that integrates the public, medical institutions, and government authorities. We test the model's universality and effectiveness against empirical data from three diverse international case studies: tuberculosis (TB) treatment adherence in Saudi Arabia, COVID-19 vaccination compliance in China, and antibiotic prescription supervision in Vietnam. Our analysis reveals that higher health risks and public exposure rates act as powerful catalysts, significantly enhancing participation from both the public and institutions, thereby accelerating the system's convergence to a stable, compliant state. We also find that medical institutions are highly sensitive to penalty intensity, adopting compliant practices only when a critical threshold is surpassed. These findings confirm the existence of a "virtuous cycle," where engaged citizens and stringent oversight collaboratively improve medical compliance, a mechanism that holds true across varied healthcare contexts. This research provides not only a validated theoretical framework but also actionable insights for policymakers to design evidence-based, participatory regulatory strategies that can enhance the resilience and sustainability of global healthcare systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.